Apyx Medical Corporation Announces Board Leadership Transition
Andrew Makrides Retiring Following More Than 40 Years of Service as Chairman of the Board of Directors; Stavros Vizirgianakis Appointed to Succeed Mr. Makrides as Chairman Apyx Medical Corporation (NASDAQ:APYX) ("Apyx
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, to
Craig-Hallum Reaffirms Their Buy Rating on Xtant Medical Holdings (XTNT)
Express News | Xtant Medical Announced The Full Commercial Launch Of Two Amniotic Membrane Allografts, SimpliGraft And SimpliMax For Chronic And Acute Wounds
Xtant Medical Announces Launch of SimpliGraft and SimpliMax for Chronic and Acute Wounds
BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)
Xtant Medical's Earnings at Risk: The Unhedged Perils of Currency Fluctuations
Q4 2023 Xtant Medical Holdings Inc Earnings Call
Xtant Medical Shares Drop 11% Following Wider 4Q Loss
By Sabela Ojea Shares of Xtant Medical on Monday after the company logged a wider loss for the fourth quarter despite seeing significant revenue growth for the period. In recent trading, shares were
Express News | Xtant Medical Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 GAAP EPS Results. Also, the Company Filed for a $150 Million Mixed Shelf Offering
Earnings Call Summary | Xtant Medical(XTNT.US) Q4 2023 Earnings Conference
The following is a summary of the Xtant Medical Holdings Inc. (XTNT) Q4 2023 Earnings Call Transcript:Financial Performance:Xtant Medical Holdings saw Q4 revenue of $28.1 million, an 84% increase year
Xtant Medical Holdings (XTNT) Receives a Buy From Craig-Hallum
Xtant Medical Holdings Inc (XTNT) Reports Record Revenue in 2023, Outpacing Analyst Estimates
Express News | Xtant Medical Holdings Inc Files For Mixed Shelf Offering Of Up To $150M
Express News | Xtant Medical Expects FY2024 Sales Of $112M-$116M Versus Consensus Of $115.95M
Xtant Medical Q4 GAAP EPS $(0.03) Misses $(0.02) Estimate, Sales $28.11M Beat $26.55M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02
Xtant Medical Holdings 4Q Rev $28.1M >XTNT
Xtant Medical Holdings 4Q Rev $28.1M >XTNT
Press Release: Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) --
Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT)
No Data